Cisplatin-based chemotherapy in renal transplant recipients: A case report and a review of the literature

Cancer

Volumn 77, Issue 1, 1996, Pages 160-163

  Benisovich, Vladimir I ^a,b   Silverman, Lewis ^a   Slifkin, Robert ^b   Stone, Nelson ^b   Cohen, Elliot ^b  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b ELMHURST HOSPITAL CENTER   (United States)

Author keywords

bladder cancer; cisplatin; cyclosporine; immunosuppression; transplantation

Indexed keywords

AZATHIOPRINE; BLEOMYCIN; CISPLATIN; CYCLOPHOSPHAMIDE; CYCLOSPORIN; DACTINOMYCIN; DOXORUBICIN; ENALAPRIL; ERYTHROPOIETIN; ETOPOSIDE; FLUOROURACIL; METHOTREXATE; PREDNISONE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; VINBLASTINE;

ADULT; ARTICLE; BLADDER CANCER; CANCER COMBINATION CHEMOTHERAPY; CASE REPORT; GRAFT REJECTION; HUMAN; HYPERTENSION; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; MALE; NEPHROTOXICITY; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION; TESTIS CANCER;

ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, TRANSITIONAL CELL; CISPLATIN; COMBINED MODALITY THERAPY; CYCLOSPORINE; DOXORUBICIN; HUMANS; KIDNEY; KIDNEY TRANSPLANTATION; MALE; METHOTREXATE; POSTOPERATIVE PERIOD; URINARY BLADDER NEOPLASMS; VINBLASTINE;

EID: 0030045821     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19960101)77:1<160::AID-CNCR26>3.0.CO;2-2     Document Type: Article

References (22)

1. Penn I. Malignancies associated with renal transplantation. Urology 1977;10:57-63.
2. Tokoro Y, Asano T, Nakagouri T, Ochiai T, Kashiwabara H, Yokiyama T, et al. A statistical study of cancer incidence in renal transplant patients. Transplant Proc 1992;24:1588-90.
3. Penn I. Cancers complicating organ transplantation. N Engl J Med 1990;323:1767-9.
4. Sternberg CN, Yagoda A, Scher HI, Watson RC, Herr HW, Morse MJ, et al. M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) for advanced transitional cell carcinoma of the urothelium. J Urol 1988;139:461-9.
5. Droz JP, Chailley J, Kreis H. Germinal cell tumors of the testis (GCTT) in renal transplant patients (RTP). Report of two cases. Khoury S, Kuss R, Murphy GP, Chatelain C, Karr JP, editors. Progress in clinical and biological research: testicular cancer. New York: Wiley-Liss, Inc., 1985;203:685-6.
6. Frantz PH, Luciani J, Khoury S, Chatelain C. Testicular cancer in a renal transplant patient. Khoury S, Kuss R, Murphy GP, Chatelain C, Karr JP, editors. Progress in clinical and biological research: testicular cancer. New York: Wiley-Liss, 1985:439.
7. Osaison A, Polackwich R. Curative platinum-based cytotoxic drug therapy in a renal transplant recipient with metastic testicular cancer. Cancer 1986;58:850-1.
8. Vogelzang NJ. Cisplatin and etoposide for metastatic testis cancer in a renal transplant recipient. J Urol 1990;143:1235-6.
9. Vogelzang NJ. Cisplatin-based chemotherapy in a renal transplant recipient [Letter]. Cancer 1992;69:3015-6.
10. Lindley CM, Gordon TR, Tremont SJ. Cisplatin-based chemotherapy in a renal transplant recipient. Cancer 1991;68:1113-7.
11. Wood DP Jr., Novick AC, Johnson DE, Streem SB, Steinmuller D. Treatment of metastatic transitional cell carcinoma following renal transplantation. Cleve Clin J Med 1989;56:61-3.
12. Thomalla JV, Leapman SB, Filio RS. Fatal transitional cell carcinoma of bladder in renal transplant recipient. Urology 1991;38:567-70.
13. Srinivas V, Deshmukh R, Shah B, Kapadia A. Cancer in a renal transplant patient. Urol Int 1993;51:167-70.
14. Teneriello M, Farley J, Parker M, O'Connor D, Shaver T, Park R, et al. Management of advanced ovarian epithelial cancer in the renal transplant patient. Gynecol Oncol 1993;50:374-8.
15. Tsurumi H, Hani K, Tsuruta T, Shirato R, Matsudaira T, Tojo A, et al. Adult T-cell leukemia developing during immunosuppressive treatment in a renal transplant recipient. Am J Hematol 1992;41:292-4.
16. Logothesis CJ, Dexeus FM, Finn L, Sella A, Amato RJ, Ayala AG, et al. A prospective randomized trial comparing MVAC and CISCA chemotherapy for patients with metastatic urothelial cancer. J Clin Oncol 1990;8:1050-5.
17. Penn I. Cancers after cyclosporine therapy. Transplant Proc 1988;20:276-9.
18. Nurmi M, Aho H. Metastasis from bladder carcinoma to renal transplant. Eur Urol 1989;16:310-1.
19. Lemmers MJ, Barry JM. De novo carcinoma of the lower urinary tract in renal allograft recipients. J Urol 1990; 144:1233-5.
20. Cockburn I, Gotz E, Gulich A, Krupp P. An interim analysis of the ongoing longterm safety study of cyclosporine in renal transplantation. Transplant Proc 1988;20:519-29.
21. Barbui T, Rambaldi A, Parenzan L, Zucchelli M, Perico N, Remuzzi G. Neurological symptoms and coma associated with doxorubicin administration during chronic cyclosporine therapy. Lancet 1992;339:1421.
22. Korstanje MJ, vanBreda Vriesman CJP, van de Staak WJBM. Cyclosporine and methotrexate: a dangerous combination. J Am Acad Dematol 1990;23:320-1.